glp-1 forum Exploring New Frontiers in Nutrition and Metabolic Health at the UC Davis Discovery Semaglutide & tirzepatide are transforming
Description
Credits: istock.org
I assume that the study is finished now
The FDA recently approved versions of GLP-1 medication - including Wegovy (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide) - for chronic weight management
Read the full article covered by Nutritional Outlook here:
Mounjaro hit $23 billion, and Zepbound added $13.5 billion
The study was published in March 2024, and found that about 10% of adults in Canada had used a GLP-1 type drug between 900,000 and 1.4 million consumers
